PDA

View Full Version : Articles of Interest

Pages : 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 [16] 17 18
  1. ER increases activity of ER- bc stems cells through paracrine EGFR & notch signaling
  2. BC tumorogenesis and the tumor microenvironment
  3. Ultra sound measures chemo response in locally advance bc
  4. Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
  5. CNS metastices after Herceptin
  6. Incidence and Risk of CNS Mets as Site of 1st Recurrence in HER2+ BC pts. & Herceptin
  7. "I Do Not Fear Death"--Roger Ebert
  8. Targeting Luminal Breast Cancer Stem Cells With Trastuzumab Blocks Metastatic Growth
  9. The Conspiracy To End Cancer
  10. Endocrine Therapy Adverse Events Predict Survival
  11. Finally a Way to Predict Bevacizumab Response?
  12. Blog Post from Metavivor
  13. Trailblazer in the Development of Combination Chemotherapy
  14. Brighton researchers' discovery may prolong cancer patients
  15. AE37 Cancer Vaccine
  16. New Endpoints Proposed for Chemotherapy in Ovarian Cancer?
  17. Batch Processing of tumor biopsies for cell markers
  18. Searching for new direction
  19. Anxiety Lingers Long After Cancer
  20. Wouldn’t It Have Been Better Not To Get Cancer In The First Place?
  21. The Risks of Cancer Screening With More Cancer Screening and Earlier Testing, Overtr
  22. Herceptin Time Line
  23. Adjuvant trastuzumab in HER2-positive breast cancer.
  24. Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
  25. BRCA1 and Cisplatin
  26. Her2 Dimerization, a refresher of oncogenic signaling
  27. Prognostication in Breast Cancer: Are We Smarter Yet?
  28. Anti-HER2 Mechanisms of Approved HER2 Inhibitors
  29. Alternatives to preventing cancer Dr. Brownstein
  30. Dennis Slamon: Anthracycline Not Needed with Trastuzumab; Nonanthracycline-based Regi
  31. From Her-2 The Making of Herceptin, a Revolutionary Treatment for Breast Cancer
  32. Cold caps tested to prevent hair loss during chemo
  33. Neoadjuvant laptinib (Tykerb) and trastuzumab (Herceptin)
  34. Afatinib, a targeted therapy that might crossover from lung cancer to Her2+ breast
  35. Gut on Fire Equals Brain on Fire
  36. The Brain's Immune System
  37. 70% of U.S. plastic surgeons use fat grafting techniques for breast reconstruction
  38. You can heal your life
  39. The Breast Cancer Reconstruction Blog
  40. Visual - How does Herceptin Work?
  41. Treating Cancer with Bicarbonate Of Soda! Baking soda
  42. Cancer Cure | Turmeric | Natural Cancer Cure
  43. Dr.Lorraine Day
  44. Par For the Cure: Dr. Dennis Slamon
  45. Dr. Finn on the Inhibition of CDK 4/6 in Breast Cancer
  46. UCLA Researchers Find Link Between Intestinal Bacteria and White Blood Cell Cancer
  47. Scientists: When diagnosing, rethink the word 'cancer'
  48. 9 million smokers should get yearly lung screening
  49. Unique treatment for early stage breast cancer
  50. "I listen with love to my body's messages" Louise L. Hay
  51. The Blood-Brain Barrier and Neuroinflammation - Dr. Datis Kharrazian
  52. Mindfulness and Cancer By Richard C. Frank, MD
  53. My Left Breast, a blog by Heather Millar
  54. Breast cancer risk can be predicted using new technique
  55. Knowing How to Be - Charles A. Moss, MD
  56. Toward Patient-Centered Drug Development in Oncology
  57. General Information About Breast Cancer
  58. A look from the financial sector on upcoming treatments - including 3Ns
  59. Personalized Medicine Gives Rise to New Ethical Questions
  60. Changing perspectives about choosing treatment
  61. Cancer Prevention Study 3
  62. New Cancer Trials focus on modifying patient's own T-Cells
  63. Functional Profiling Leads to Identification of Accurate Genomic Findings
  64. Cancer Prehabilitation: An Opportunity to Decrease Treatment-Related Morbidity
  65. Patterns of Recurrence Differ by Breast Cancer Node-Negative Subtype
  66. Pertuzumab Granted Priority Review for Neoadjuvant HER2-Positive Breast Cancer
  67. Is Soluble Her2 the same as Serum Her2? anyone know?
  68. Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer
  69. Ductal Carcinoma In Situ of the Breast: ‘Making the Punishment Fit the Crime’
  70. Exploiting the Metabolic Demands of Senescent Cancer Cells
  71. Researchers uncover details behind breast cancer growth
  72. Her2 treatment crossing over to the Triple Negatives
  73. “Good” Patients and “Difficult” Patients — Rethinking Our Definitions
  74. European subcutaneous trastuzumab
  75. Message re: Free my genes
  76. A genome-wide association study of chemotherapy-induced alopecia in bc
  77. The Annual Report to the Nation on the Status of Cancer, 1975-2009
  78. 20% decrease in Cancer death
  79. Targeted Vs Chemo - and targeted wins!
  80. Tykerb? Better with Herceptin for MBC
  81. New study on acquired Lapatinib resistance
  82. Study of late vs. early relapse in ER+ breast cancer
  83. Review article of inflammation related breast cancer progression
  84. HER2 overexpression renders human breast cancers sensitive to PARP inhibition
  85. In cancer drug battle, both sides appeal to ethics
  86. José Baselga, MD, PhD
  87. Andrew Dannenberg, MD
  88. Nancy E. Davidson, MD
  89. Angelo Di Leo, MD, PhD
  90. Mitch Dowsett, PhD, BSc
  91. H. Shelton Earp, MD
  92. Matthew J. Ellis, MD, PhD
  93. Hyman B. Muss, MD
  94. Larry Norton, MD
  95. George W. Sledge, Jr., MD
  96. Questions about Valley breast cancer charity, where donation money is really used
  97. Definitions of Stage IV vs. Metastatic Breast Cancer
  98. Breakthrough Designation Granted to Entinostat for Advanced Breast Cancer
  99. HER2-positive tumors with mutations in PIK3CA . . .
  100. How Molecular Profiling Works
  101. Chargers Partner with Breast Cancer Org for Free Mammograms
  102. Angiogenesis in Breast Cancer
  103. About 75% of NIH's employees -- or about 14,700 people -- have been furloughed
  104. Oligometastases . . . since Cool Breese introduced this term . . .
  105. Functional profiling article 10/8/13 in NewsMedical
  106. Why Oncologists Don’t Like In Vitro Chemosensitivity Tests
  107. How to Get into the Brain
  108. Synta Announces ENCHANT-1 Breast Cancer Results Support Transition to Second Stage of
  109. NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the grow
  110. Clinical Trials Continue Only at a Crawl
  111. Role of Viruses Among 19 Cancers
  112. Dacomitinib (PF-00299804), an irreversible Pan-HER inhibitor
  113. AMG 900, pan-Aurora kinase inhibitor
  114. Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimen
  115. Inhibition of HSP90 with AUY922 induces synergy in HER2-amplified trastuzumab-resista
  116. Pattern of recurrence of early bc differs by intrinsic subtype & proliferation index
  117. Pubertal high fat diet: effects on mammary cancer
  118. The challenge of reporting dense breasts
  119. targeting of erbB3 with MM-121/SAR256212 enhances paclitaxel
  120. Unicorn search: MM-302 is a HER2-targeted nanotherapeutic
  121. Understanding Perjeta & Perjeta with Herceptin
  122. What Should HER2/Neu Breast Cancer Patients And Survivors Eat? Food for Breast Cancer
  123. Obesity changes in fat stem cells mediate tumor growth via ER stimulation
  124. Suspension of ponatinib marketing & sales
  125. 10 year Herceptin statistics, for inquiring minds
  126. NeuVax™ (nelipepimut-S)
  127. Status of AE37 vaccine
  128. Beautiful tattoos for reconstructed breasts
  129. Quantitative assessment Ki-67 score for prediction
  130. Pathological responses and long-term outcome analysis after neoadjuvant chemotheraphy
  131. Mammographic density and risk of breast cancer by age and tumor characteristics.
  132. Neuregulin autocrine signaling promotes self-renewal of breast tumor-initiating cells
  133. When a friend is sick
  134. Flax Oil and Herceptin
  135. Test Shown to Reduce Early Cancer Deaths is Now Available to Patients
  136. What Does Cancer Smell Like?
  137. Exemestane may have benefits beyond those of an AI
  138. Breast Reconstruction After Radiation
  139. Cancer Drug Costs
  140. The mind, inflammation, and epigenetics
  141. ultra-deep targeted sequencing for personalized bc care
  142. Rads and the myth of chemo wiping out that "last stray cancer cell"
  143. Delivery of gene silencing agents for breast cancer therapy
  144. No Equivalence for Paclitaxel vs Doxorubicin/Cyclophosphamide
  145. Six Cycles of Doxorubicin and Cyclophosphamide or Paclitaxel Are Not Superior to Four
  146. Mekinist (Trametinib) a MEK Kinase inhibitor
  147. Understanding vaccines E75/AE37
  148. The sequential use of endocrine treatment for advanced breast cancer: where are we?
  149. Pertuzumab
  150. Smoking and Estrogen in Breast Cancer
  151. We have a title: e-Patient
  152. Blocking metabolic pathways eradicates Acute Leukemia (in Mice)
  153. The genomic map of breast cancer: which roads lead to better targeted therapies?
  154. The Downside To Clinical Trials
  155. NeuVax Patent in Australia
  156. Cancer, from the 100 Most Important Science Ideas
  157. Fighting fire's GP2 info request
  158. Palliative Chemo Can Make It More Likely You'll Die In The ICU
  159. Cooling Cap trial in Los Angeles, CA
  160. Whole genome sequencing; not ready for prime time
  161. Health law concerns for cancer centers
  162. Epigenetics
  163. Diversity improves scientific papers
  164. Could This Be The End Of Cancer?
  165. Post-meno hormone tx and effects on bc risk
  166. Herceptin works with immune cells to downregulate cancer cells
  167. From the NEJM: Hazards of Hindsight — Monitoring the Safety of Nutritional Supplement
  168. Pablociclib New Drug
  169. Intermittent Lapatinib Hits Roadblock in HER2 Breast Cancer Study
  170. From the NEJM: Comparative Effectiveness Questions in Oncology
  171. Immunological Research: A multi-faceted approach to curing disease
  172. Circulating nucleic acids as biomarkers in breast cancer
  173. Aromatase Inhibition and Cognitive Function in Breast Cancer
  174. When "HRT" may differ in effects
  175. Phase 2 study in neoadjuvant, HER2 3+ Breast Cancer Patients to commence in 2014
  176. DNA The secret of Life
  177. Who is Cold Spring Harbor Laboratory?
  178. What are Estrogens? National Cancer Institute information
  179. Estrogen and Cancer. National Cancer Institute
  180. Antiestrogens. National Cancer Institute
  181. Aromatase Inhibitors. National Cancer Institute
  182. Estrogen Receptor-Negative Breast Cancer. NCI
  183. Tamoxifen and Breast Cancer Prevention. NCI
  184. Need for better SERMs. NCI
  185. Estrogen Replacement in Menopause. NCI
  186. Raloxifene and the Prevention of Osteoporosis
  187. Tamoxifen Mechanism
  188. Against Metastasis: Brunhilde Felding-Habermann
  189. ER PR Her2 Ki67 & Tamoxifen
  190. Synergistic Interactions between Tamoxifen and Trastuzumab (Herceptin)
  191. herb-drug interference in human breast cancer cells treated with tamoxifen and trastu
  192. Phosphorylated p-70S6K Predicts Tamoxifen Resistance in Postmenopausal Breast Cancer
  193. Breast Cancer Survival Defined by the ER/PR/HER2
  194. Generex Announces Presentation of Primary Efficacy Data & Immunological Response from
  195. Has anyone in the UK taken the Pam50 and opted out of chemo??
  196. KRAS-variant associated with breast, ovarian cancer risk
  197. Tumor stage affects risk and prognosis of contralateral breast cancer
  198. Prognosis of metachronous contralateral breast cancer
  199. Vaccine Boosters Reduce Recurrence of Breast Cancer
  200. Biotech Makes Personalized Cancer Vaccines Using Tumor Samples
  201. Construction and evaluation of a novel humanized HER2-specific chimeric
  202. $2.5M Grant To Solve Mystery of Cancer (Cold Spring Harbor)
  203. overcoming resistance with HER2 targeted breast and gastric cancer treatments
  204. Insurers push back against growing cost of cancer treatments
  205. New Discoveries in Cancer and Heart Disease
  206. Preventing early menopause in ER negative breast cancer
  207. BreastCancer.org tips on Post-Traumatic Stress Disorder (PTSD)
  208. For cancer patients, new tool predicts financial pain
  209. Commentary on Study about Cancer Center Advertising
  210. High recurrence risk small HER2+ cancers
  211. Metformin-Promising News In A Non-Conclusive Area
  212. Researchers Find Gene Signature Predictive of Late Distant Recurrence
  213. Adding Lapatinib to Trastuzumab Does Not Lengthen the Lives of Women with HER2+
  214. New Discovery Opens the Door to Possible Cure for Heart Disease
  215. Don’t judge every tumor by its tissue, scientists say
  216. When Patients Read What Their Doctors Write
  217. Quest for Targeted Therapeutic 'Cocktails' Hits Roadblocks
  218. Molecular effects of lapatinib in patients with HER2+ DCIS
  219. Novel vaccine cuts recurrence in HER2 positive breast cancer patients
  220. Immune approaches to the treatment of breast cancer, around the corner?
  221. Training Dogs to Sniff Out Cancer
  222. New Therapy Seeks to Mature Rather Than Kill Cancer Cells
  223. Immune approaches to the treatment of breast cancer, around the corner?
  224. Threats to Cancer Care
  225. Bevacizumab Improves Survival in Metastatic Breast Cancer
  226. NJEM correspondence on SOFT Trial (Her2+ related)
  227. CLEOPATRA Trial Changes Standard Therapy for Metastatic HER2 Positive Breast Cancer
  228. 3D-Prints Skin For Breast Cancer Survivors
  229. Immune approaches to the treatment of breast cancer, around the corner?
  230. The power of the placebo effect
  231. Calculating the steeper costs of cancer
  232. Research on obesity and bc reveals signaling pathway
  233. Breast cancer's 'dual citizens'
  234. Update on Herceptin Trials
  235. METAvivor receives the largest grant in its history
  236. Methadone as a new cancer treatment drug
  237. For Anyone Who Has Trouble Swallowing Pills
  238. Anyone heard of Blushwood Fruit?
  239. Coming treatments: Pfizer's Palbociclib
  240. Looking for upcoming Unicorns (miracle treatments)
  241. How Medical Care Is Being Corrupted
  242. Overlooking Evolution: A Systematic Analysis of Cancer Relapse and Therapeutic Resist
  243. NCI funds Univ. of Chicago genomics project
  244. Article on WA Univ Breast Cancer Vaccine Trial
  245. New Drug Combo
  246. Bisphosphonates effective against Her2+ BC
  247. http://www.oncologypractice.com/home/article/video-low-recurrence-with-high-her2-expr
  248. Mistaken Identities Plague Lab Work With Human Cells
  249. Oncogenic Alterations in ERBB2/HER2 Represent Potential Therapeutic Targets
  250. Shorter Canadian radiation at higher dose vs US